|
![]() |
|||
|
||||
OverviewThe aim of the book is to provide an in-depth review of our current understanding of the pathogenesis of both asthma and COPD. This volume also discusses the promising new options for pharmacological intervention of these diseases. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of lung biology. Full Product DetailsAuthor: Clive P. Page , Peter J. BarnesPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: 2004 ed. Volume: 161 Dimensions: Width: 15.50cm , Height: 2.20cm , Length: 23.50cm Weight: 0.824kg ISBN: 9783540004646ISBN 10: 3540004645 Pages: 378 Publication Date: 07 January 2004 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of Contents1. Current Drugs.- ?-Adrenoceptor Agonists.- Anticholinergic Bronchodilators.- Theophylline in the Treatment of Respiratory Disease.- Corticosteroids.- Mediator Antagonists and Anti-Allergic Drugs.- 2. Future Drugs.- New Bronchodilator Drugs.- Selective Phosphodiesterase Inhibitors in the Treatment of Respiratory Disease.- Cytokine Modulators.- Inhibitors of Leucocyte—Endothelial Adhesion as Potential Treatments for Respiratory Disease.- New Antiallergic Drugs.- Pharmacogenetics, Pharmacogenomics and Gene Therapy.- Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs.- Novel Anti-inflammatory Therapies.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |